Magnus, Per, Brubakk, Oddbjørn, Nyland, Harald et al. · Vaccine · 2009 · DOI
This study investigated whether a meningococcal vaccine given to teenagers in Norway in 1988-1989 was linked to the later development of ME/CFS. Researchers compared 201 people diagnosed with ME/CFS to 389 people without the condition and found no meaningful difference in vaccination rates between the two groups. The findings suggest that receiving this particular vaccine as a teenager does not increase the risk of developing ME/CFS.
Given ongoing public concerns about vaccines and ME/CFS, this study provides empirical evidence addressing one specific vaccine and CFS/ME risk in a defined population. Understanding environmental and biological triggers of ME/CFS remains crucial for patients seeking answers about disease etiology and prevention strategies.
This study does not prove that vaccines in general are safe regarding ME/CFS risk, nor does it rule out other specific vaccines or vaccination schedules as potential triggers. A single negative finding in one population cannot exclude rare or population-specific associations, and the study's retrospective design limits ability to establish temporal causality with certainty.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.